en

PRODUCT DETAIL

Phesgo 1 200 mg/600 mg injekčný roztok

Code 6277D
MA number EU/1/20/1497/001
Product Form: sol inj 1x15 ml/1200 mg/600 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XY Combinations of antineoplastic agents
L01XY02 Pertuzumab and trastuzumab
Shelf life: 18
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 21.12.2020
Validity: 21.12.2025
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.12.2020
eu-flag.png sk-flag.png